|
Mar 28
|
Why Is Corcept (CORT) Down 5.3% Since Last Earnings Report?
|
|
Mar 26
|
3 Reasons to Sell CORT and 1 Stock to Buy Instead
|
|
Mar 21
|
Is Corcept Therapeutics (CORT) Stock Outpacing Its Medical Peers This Year?
|
|
Mar 19
|
3 Growth Stocks in Hot Water
|
|
Mar 14
|
1 Small-Cap Stock on Our Buy List and 2 to Avoid
|
|
Mar 11
|
Top Growth Companies With Significant Insider Ownership
|
|
Mar 10
|
Corcept Therapeutics Initiates MOMENTUM Trial to Determine Prevalence of Hypercortisolism in Patients with Resistant Hypertension
|
|
Mar 7
|
Corcept Shares Rise More Than 55% in 6 Months: Here's Why
|
|
Mar 7
|
Are Options Traders Betting on a Big Move in Corcept Therapeutics (CORT) Stock?
|
|
Feb 12
|
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2024 Financial Results, Provide Corporate Update and Host Conference Call
|
|
Dec 31
|
Corcept Submits Application for Another Cushing's Syndrome Drug
|
|
Dec 30
|
Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients With Hypercortisolism
|